451 related articles for article (PubMed ID: 10473919)
1. Systemic fungal infections in patients with hematologic malignancies: indications and limitations of the antifungal armamentarium.
Böhme A; Karthaus M
Chemotherapy; 1999; 45(5):315-24. PubMed ID: 10473919
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases].
Karthaus M; Böhme A
Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423
[TBL] [Abstract][Full Text] [Related]
3. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
4. Therapy for fungal infections in leukemia.
Segal RE; Minamoto GY
Curr Oncol Rep; 2001 May; 3(3):201-8. PubMed ID: 11296129
[TBL] [Abstract][Full Text] [Related]
5. Emerging fungal pathogens, drug resistance and the role of lipid formulations of amphotericin B in the treatment of fungal infections in cancer patients: a review.
Viscoli C; Castagnola E
Int J Infect Dis; 1998-1999 Winter; 3(2):109-18. PubMed ID: 10225990
[TBL] [Abstract][Full Text] [Related]
6. [Potential of anidulafungin in hematological patients].
Vázquez López L; Ruiz Camps I
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():44-50. PubMed ID: 19572434
[TBL] [Abstract][Full Text] [Related]
7. Antifungal treatment in patients with cancer.
Viscoli C; Castagnola E; Machetti M
J Intern Med Suppl; 1997; 740():89-94. PubMed ID: 9350188
[TBL] [Abstract][Full Text] [Related]
8. [Prophylaxis against mycoses in neutropenic patients].
Arning M; Aul C
Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
[TBL] [Abstract][Full Text] [Related]
9. Treatment of invasive fungal infections.
Warnock DW
Hosp Med; 1998 Apr; 59(4):266-7. PubMed ID: 9722362
[No Abstract] [Full Text] [Related]
10. [Update on therapy of invasive mycoses in hematology and oncology].
Maschmeyer G; Haas A; Böhme A
Dtsch Med Wochenschr; 2005 Jun; 130(22):1381-4. PubMed ID: 15915381
[No Abstract] [Full Text] [Related]
11. Itraconazole in neutropenic patients.
van't Wout JW
Chemotherapy; 1992; 38 Suppl 1():23-6. PubMed ID: 1319311
[TBL] [Abstract][Full Text] [Related]
12. Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol.
Castagnola E; Bucci B; Montinaro E; Viscoli C
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():97-106. PubMed ID: 8932808
[TBL] [Abstract][Full Text] [Related]
13. Therapy of invasive fungal infections.
Kullberg BJ; de Pauw BE
Neth J Med; 1999 Sep; 55(3):118-27. PubMed ID: 10509070
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
Viscoli C; Castagnola E
Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis and treatment of fungal infections associated with haematological malignancies.
Ascioglu S; de Pauw BE; Meis JF
Int J Antimicrob Agents; 2000 Aug; 15(3):159-68. PubMed ID: 10926437
[TBL] [Abstract][Full Text] [Related]
16. Management of invasive mycoses in hematology patients: current approaches.
Perfect JR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):5-14. PubMed ID: 15651177
[TBL] [Abstract][Full Text] [Related]
17. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K
Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349
[TBL] [Abstract][Full Text] [Related]
18. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J
Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
[TBL] [Abstract][Full Text] [Related]
19. Strategies for managing systemic fungal infection and the place of itraconazole.
Potter M
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i49-i54. PubMed ID: 16120634
[TBL] [Abstract][Full Text] [Related]
20. Changing strategies for treatment of systemic mycoses.
Graybill JR
Braz J Infect Dis; 2000 Apr; 4(2):47-54. PubMed ID: 11012295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
